138 related articles for article (PubMed ID: 10027652)
1. The SATE pronucleotide approach applied to acyclovir: part II. Effects of bis(SATE)phosphotriester derivatives of acyclovir on duck hepatitis B virus replication in vitro and in vivo.
Hantz O; Périgaud C; Borel C; Jamard C; Zoulim F; Trépo C; Imbach JL; Gosselin G
Antiviral Res; 1999 Jan; 40(3):179-87. PubMed ID: 10027652
[TBL] [Abstract][Full Text] [Related]
2. The S-acyl-2-thioethyl pronucleotide approach applied to acyclovir: part I. Synthesis and in vitro anti-hepatitis B virus activity of bis(S-acyl-2-thioethyl)phosphotriester derivatives of acyclovir.
Périgaud C; Gosselin G; Girardet JL; Korba BE; Imbach JL
Antiviral Res; 1999 Jan; 40(3):167-78. PubMed ID: 10027651
[TBL] [Abstract][Full Text] [Related]
3. Oral famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo.
Tsiquaye KN; Slomka MJ; Maung M
J Med Virol; 1994 Mar; 42(3):306-10. PubMed ID: 8006644
[TBL] [Abstract][Full Text] [Related]
4. Effect of nucleoside analogue therapy on duck hepatitis B viral replication in hepatocytes and bile duct epithelial cells in vivo.
Nicoll A; Locarnini S; Chou ST; Smallwood R; Angus P
J Gastroenterol Hepatol; 2000 Mar; 15(3):304-10. PubMed ID: 10764033
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activities of penciclovir and famciclovir on duck hepatitis B virus in vitro and in vivo.
Offensperger WB; Offensperger S; Keppler-Hafkemeyer A; Hafkemeyer P; Blum HE
Antivir Ther; 1996 Aug; 1(3):141-6. PubMed ID: 11322247
[TBL] [Abstract][Full Text] [Related]
6. In vitro antihepadnaviral activities of combinations of penciclovir, lamivudine, and adefovir.
Colledge D; Civitico G; Locarnini S; Shaw T
Antimicrob Agents Chemother; 2000 Mar; 44(3):551-60. PubMed ID: 10681317
[TBL] [Abstract][Full Text] [Related]
7. The guanine nucleoside analog penciclovir is active against chronic duck hepatitis B virus infection in vivo.
Lin E; Luscombe C; Wang YY; Shaw T; Locarnini S
Antimicrob Agents Chemother; 1996 Feb; 40(2):413-18. PubMed ID: 8834889
[TBL] [Abstract][Full Text] [Related]
8. 2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo.
Zoulim F; Dannaoui E; Borel C; Hantz O; Lin TS; Liu SH; Trépo C; Cheng YC
Antimicrob Agents Chemother; 1996 Feb; 40(2):448-53. PubMed ID: 8834896
[TBL] [Abstract][Full Text] [Related]
9. Effect of alcohol extract of Acanthus ilicifolius L. on anti-duck hepatitis B virus and protection of liver.
Wei PH; Wu SZ; Mu XM; Xu B; Su QJ; Wei JL; Yang Y; Qin B; Xie ZC
J Ethnopharmacol; 2015 Feb; 160():1-5. PubMed ID: 25446633
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of 2'-fluoro-5-methyl-beta-L-arabinofuranosyl-uracil on duck hepatitis B virus replication.
Aguesse-Germon S; Liu SH; Chevallier M; Pichoud C; Jamard C; Borel C; Chu CK; Trépo C; Cheng YC; Zoulim F
Antimicrob Agents Chemother; 1998 Feb; 42(2):369-76. PubMed ID: 9527788
[TBL] [Abstract][Full Text] [Related]
11. Protocatechuic aldehyde inhibits hepatitis B virus replication both in vitro and in vivo.
Zhou Z; Zhang Y; Ding XR; Chen SH; Yang J; Wang XJ; Jia GL; Chen HS; Bo XC; Wang SQ
Antiviral Res; 2007 Apr; 74(1):59-64. PubMed ID: 17298850
[TBL] [Abstract][Full Text] [Related]
12. Antiviral effects of PNA in duck hepatitis B virus infection model.
Chen ZY; Cheng AC; Wang MS; Xu DW; Zeng W; Li Z
Acta Pharmacol Sin; 2007 Oct; 28(10):1652-8. PubMed ID: 17883953
[TBL] [Abstract][Full Text] [Related]
13. The effect of Gankang Suppository on duck hepatitis B virus, serum biochemistry and liver histology in ducklings.
Li H; Tian D; Wu H; Chen M; Chen A
J Huazhong Univ Sci Technolog Med Sci; 2008 Aug; 28(4):421-5. PubMed ID: 18704303
[TBL] [Abstract][Full Text] [Related]
14. Long-term therapy with the guanine nucleoside analog penciclovir controls chronic duck hepatitis B virus infection in vivo.
Lin E; Luscombe C; Colledge D; Wang YY; Locarnini S
Antimicrob Agents Chemother; 1998 Aug; 42(8):2132-7. PubMed ID: 9687423
[TBL] [Abstract][Full Text] [Related]
15. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.
Fourel I; Cullen JM; Saputelli J; Aldrich CE; Schaffer P; Averett DR; Pugh J; Mason WS
J Virol; 1994 Dec; 68(12):8321-30. PubMed ID: 7966625
[TBL] [Abstract][Full Text] [Related]
16. New insights regarding the potential of the pronucleotide approach in antiviral chemotherapy.
Gosselin G; Girardet JL; Périgaud C; Benzaria S; Lefebvre I; Schlienger N; Pompon A; Imbach JL
Acta Biochim Pol; 1996; 43(1):196-208. PubMed ID: 8790724
[TBL] [Abstract][Full Text] [Related]
17. [Anti-virus effect of hepatocyte stimulating substance (HSS) on duck hepatitis B virus in vivo].
Chen G; Chen J; Liu D; Zhang X; Zhu C; Li Y; Wang L; Yang Y; Cai G; Han F
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):329-32. PubMed ID: 15617240
[TBL] [Abstract][Full Text] [Related]
18. In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus.
Shaw T; Amor P; Civitico G; Boyd M; Locarnini S
Antimicrob Agents Chemother; 1994 Apr; 38(4):719-23. PubMed ID: 8031035
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of duck hepatitis B virus replication by 2',3'-dideoxy-3'-fluoroguanosine in vitro and in vivo.
Hafkemeyer P; Keppler-Hafkemeyer A; al Haya MA; von Janta-Lipinski M; Matthes E; Lehmann C; Offensperger WB; Offensperger S; Gerok W; Blum HE
Antimicrob Agents Chemother; 1996 Mar; 40(3):792-4. PubMed ID: 8851615
[TBL] [Abstract][Full Text] [Related]
20. Effects of pyrimidine and purine analog combinations in the duck hepatitis B virus infection model.
Seignères B; Martin P; Werle B; Schorr O; Jamard C; Rimsky L; Trépo C; Zoulim F
Antimicrob Agents Chemother; 2003 Jun; 47(6):1842-52. PubMed ID: 12760857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
